Komori
Governance4967KOBAYASHI PHARMACEUTICAL CO.,LTD.Materials and Chemicals

Articles of Incorporation 2026/03/27

The Articles of Incorporation revised on 27 March 2026 set out the corporate structure as a company with an Audit and Supervisory Committee, the maximum number of directors, and other matters. However, the text does not specify what has changed from before the revision.

Worth reading
85Important
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee
Number of directorsNo more than 10 directors, including no more than 5 directors serving as Audit and Supervisory Committee members
Committee1
Audit and Supervisory Committee
Changes this time

The report does not state what has changed since the previous report.

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee
Number of directorsNo more than 10 directors, including no more than 5 directors serving as Audit and Supervisory Committee members
CommitteeAudit and Supervisory Committee (proportion of outside members: Not disclosed)
Changes this timeThe report does not state what has changed since the previous report.
Items this document does not state (4)
Number of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The document does not state the reason for amending the Articles of Incorporation.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Articles of Incorporation 2026/03/27 | KOBAYASHI PHARMACEUTICAL CO.,LTD. (4967) timely disclosure | Komori